Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O V Gotko"'
Publikováno v:
Russian Clinical Laboratory Diagnostics. 67:277-285
Non-small cell lung cancer (NSCLC) occupies the first place in the structure of mortality due to oncological diseases. Late diagnosis worsens the effectiveness of its treatment. There are no informative biomarkers that allow us to judge the prevalenc
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 16:154-163
Autor:
A. D. Tahanovich, N. N. Kauhanka, V. I. Prohorova, D. I. Murashko, A. V. Kolb, O. V. Gotko, V. A. Matusevich
Publikováno v:
Proceedings of the National Academy of Sciences of Belarus, Medical series. 19:91-102
Only 60-70 % patients with stage I and 35-40 % with stage II of non-small cell lung cancer (NSCLC) overcome the 5-year survival. The reason for such a high mortality rate is almost always a disease recurrence due to the presence of hidden metastases.
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 16:45-53
Publikováno v:
Biomeditsinskaia khimiia. 67(5)
In the structure of lung cancer incidence most cases belong to non-small cell lung cancer (NSCLC) which is subdivided into two histological subtypes: adenocarcinoma (AC) and squamous cell carcinoma (SCC). A five-year survival rate of patients with st